Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut
Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
About Half of Americans Approve of Using Weight-Loss Drugs to Treat Obesity, AP-NORC Poll Finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...
The high cost of weight loss: How patients are fighting for access to breakthrough medications
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
Hosted on MSN2h
AquaSculpt Review: Can This ‘Ice Water Hack’ Truly Transform Weight Loss?
In a world where weight loss methods are often tedious and ineffective, AquaSculpt emerges as a revolutionary approach that ...
First for Women on MSN2h
Amycretin Shows Promising 22% Weight Loss in Trials-It May Rival Ozempic
Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...
‘The Challenge’ Star Aneesa Ferreira Shows Off Impressive Weight Loss & Fans Praise Her ‘Motivation’
Ferreira, who is 43 years old, pointed out that losing weight doesn’t get any easier with age. “Factor in genetics, surgeries ...
Weight-loss drug developer Metsera raises $275 million in US IPO
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
Hindustan Times13h
Weight Loss
Mahtab shared five realistic tips on how to get back to the weight loss routine after having a high-calorie day or a weekend.